Evidence map›Paper›PMID 42030149›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS.

Valentina Varela, Santiago Garcimartín, Emiliano Trias, Ari Zeida, Monique Richter, Andrés de León, Ernesto Miquel, Peter H King, Brigitte Vulliez-Le Normand, Mariano Martinez and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Valentina Varela *Laboratorio de Neurodegeneración, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Santiago Garcimartín *Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.ORCID 0009-0000-6122-3660
Emiliano Trias *Departamento de Neurobiología Celular y Molecular, Instituto de Investigaciones Biológicas Clemente Estable Montevideo, Montevideo 11600, Uruguay.
Ari ZeidaDepartamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.ORCID 0000-0003-0938-287X
Monique RichterLaboratorio de Neurodegeneración, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Andrés de LeónLaboratorio de Neurodegeneración, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Ernesto MiquelDepartamento de Histología y Embriología, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.
Peter H KingDepartment of Neurology and Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama, Birmingham, AL 35294.
Brigitte Vulliez-Le NormandUnité de Microbiologie Structurale, Département de Biologie Structurale et Chimie, Institut Pasteur, CNRS, Université Paris Cité, Paris 75015, France.
Mariano MartinezUnité de Microbiologie Structurale, Département de Biologie Structurale et Chimie, Institut Pasteur, CNRS, Université Paris Cité, Paris 75015, France.ORCID 0000-0003-4460-8045
Pedro M AlzariUnité de Microbiologie Structurale, Département de Biologie Structurale et Chimie, Institut Pasteur, CNRS, Université Paris Cité, Paris 75015, France.ORCID 0000-0002-4233-1903
Silvina BartesaghiDepartamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.
Rafael RadiDepartamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.ORCID 0000-0002-1114-1875
Luis BarbeitoLaboratorio de Neurodegeneración, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.

Funding

UdelaR | Comisión Sectorial de Investigación Científica (CSIC) CSIC I _ 2023UdelaR | Comisión Sectorial de Investigación Científica (CSIC) CSIC I + D _ 2022Universidad de la República Uruguay (UdelaR) EI_2020
6 · The paper itself

Abstract

Nerve growth factor (NGF) is a member of the neurotrophin family, essential for neuronal survival and phenotypic maintenance. However, in vitro, its function can be disrupted by oxidative posttranslational modifications such as tyrosine nitration. Nitrated NGF (NO

Indexed as

Amyotrophic Lateral SclerosisNerve DegenerationNerve Growth FactorAnimalsAntibodies, MonoclonalFemaleHumansMaleMiceMice, Inbred BALB CMotor NeuronsNitro CompoundsOxidation-ReductionPC12 CellsRatsRats, Sprague-DawleyAntibodies, MonoclonalNerve Growth FactorNitro CompoundsALScrystallographymonoclonal antibodiesnerve growth factortyrosine nitration

Identifiers

PMID42030149
PMCPMC13123920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.